- Total revenues came in at $74.5 billion in the first three months of 2024, up 11% year-over-year
- Earnings per share from continuing operations was $7.02 in Q1, compared to $5.25 last year
- Adjusted earnings per share increased 25% year-over-year to $7.27
- McKesson’s board of directors approved a $6.0 billion increase to the company’s share repurchase program
- For fiscal 2024, the management expects adjusted earnings per share to be between $26.55 and $27.35
Market News
Earnings Summary: A snapshot of McKesson Corporation’s Q1 2024 report
McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and governments, on Wednesday reported financial results for the first quarter of 2024. Total revenues came in at $74.5 billion in the first three months of 2024, up 11% year-over-year Earnings per share from continuing operations […]
“McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and governments, on Wednesday reported financial results for the first quarter of 2024. Total revenues came in at $74.5 billion in the first three months of 2024, up 11% year-over-year Earnings per share from continuing operations […]
· August 2, 2023
McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and governments, on Wednesday reported financial results for the first quarter of 2024.
ADVERTISEMENT